The Catalent Applied Drug Delivery Institute announced that it is to hold a one-day symposium entitled “Smart Drug Development and Design” on Wednesday, Feb. 13, 2019 at Boehringer Ingelheim’s campus in Danbury, Connecticut.
The event will be chaired by Cornell Stamoran, Ph.D., Co-Chair of the Catalent Applied Drug Delivery Institute and will feature scientific experts from leading pharmaceutical companies, including Keith Horspool, Ph.D., Vice President, Pharmaceutics, Boehringer Ingelheim. The event will explore the key considerations for transitioning a molecule from discovery to Phase 1 readiness, including API and formulation development, pharmacokinetics, quality and CMC requirements, as well as the incorporation of patient-focused design concepts. The agenda is highly interactive with activities designed for the audience to work in teams to apply the principles from the presentations, and with ample time for networking.
“Despite advances in science and technology, the pharmaceutical industry faces high attrition rates. The experts at these workshops will share strategies that can be employed during preclinical and early clinical stages of drug development that can potentially improve chances of success,” commented Dr. Stamoran.
Established in 2012, the Catalent Applied Drug Delivery Institute employs a multi-tiered approach to accelerate the adoption of advanced drug delivery technologies to improve patient outcomes.
